Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug induced morphologic changes in the liver.

P R Foulis1, B H Sanford, M Gottfried

  • 1Department of Pathology, University of South Florida, Tampa 33612.

Annals of Clinical and Laboratory Science
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database.

Prostate cancer and prostatic diseases·2017
Same author

[Molecular diagnostics of lung cancer].

Magyar onkologia·2015
Same author

Climate effects on mountain plants.

Nature·2013
Same journal

<i>Letter to the Editor:</i> Detection of <i>Chlamydia trachomatis</i> Immunoglobulin E Antibody in Human Sera.

Annals of clinical and laboratory science·2026
Same journal

Comparison of the DNA Preservation Capacity of Two Methods for the Long-Term Cryopreservation of Whole Blood Samples.

Annals of clinical and laboratory science·2026
Same journal

Recurrence of Primary Mediastinal Yolk Sac Tumor with Brain Metastases: A Case Report and Literature Review.

Annals of clinical and laboratory science·2026
Same journal

Intraoperative Imprint Cytology of <i>SMARCB1</i>-Mutant Desmoplastic Myxoid Tumor of the Pineal Region: A Case Report with Cytologic Differential Diagnosis and Literature Review.

Annals of clinical and laboratory science·2026
Same journal

Bergenin Suppresses Glycolysis and Malignant Progression in Breast Cancer via the IGF1R-MAPK Signaling Pathway.

Annals of clinical and laboratory science·2026
Same journal

Network Pharmacology and <i>in vitro</i> Experimental Validation Reveal the Anticancer Mechanisms of Cichoric Acid in Cervical Cancer.

Annals of clinical and laboratory science·2026
See all related articles

Evaluating drug-induced liver injury is challenging due to the liver

Area of Science:

  • Hepatology and Toxicology
  • Drug-induced liver injury (DILI)
  • Pathologic evaluation of hepatic changes

Background:

  • The liver's limited histologic response to hepatotoxins complicates the pathologic evaluation of drug-induced hepatic changes.
  • Drug-induced liver injury (DILI) commonly manifests as cholestasis, hepatitis, or a combination of both.
  • Understanding predictable (dose/duration-dependent) and unpredictable (idiosyncratic) DILI is crucial for diagnosis.

Purpose of the Study:

  • To highlight the diagnostic challenges in evaluating drug-induced liver injury (DILI).
  • To emphasize the importance of clinical history in differentiating DILI from other hepatic conditions.
  • To underscore the liver's susceptibility to drug toxicity due to its central role in drug metabolism.

Main Methods:

Related Experiment Videos

  • Review of pathologic findings in drug-induced hepatic damage.
  • Analysis of predictable versus unpredictable drug toxicity mechanisms.
  • Emphasis on integrating clinical history with histologic evaluation for accurate diagnosis.

Main Results:

  • Most hepatotoxins cause cholestasis or hepatitis.
  • Morphologic liver alterations often reverse upon discontinuing the offending agent, but some drugs can lead to cirrhosis or chronic hepatitis.
  • Histologic changes can mimic other liver diseases, necessitating thorough clinical correlation.

Conclusions:

  • Accurate diagnosis of drug-induced liver injury (DILI) requires a comprehensive clinical history.
  • Histologic evaluation alone can be misleading, as drug-induced changes may resemble other hepatic pathologies.
  • Clinicians must consider DILI due to the liver's critical role in drug metabolism and vulnerability to toxic effects.